Skip to content

Efficacy and Safety of a New Sperm Capacitation Method

Efficacy and Safety of a New Sperm Capacitation Method: a Prospective in Vitro Study on Semen Samples

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06742437
Acronym
HyperSperm01
Enrollment
300
Registered
2024-12-19
Start date
2025-01-14
Completion date
2026-09-01
Last updated
2026-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthenozoospermia, Male Infertility, Oligozoospermia, Reproductive Issues, Teratozoospermia

Brief summary

Prospective, multicenter research study with a split-sample design on semen samples, without intervention, to evaluate the efficacy and safety of HyperSperm, a new sperm capacitation method, in 300 semen samples with various characteristics and abnormalities, in an in vitro study over 12 months.

Interventions

Sperm samples in the control group will undergo traditional processing

Sperm samples in the experimental group will undergo product-specific processing

Sponsors

Fecundis Lab SL
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Ability to provide a semen sample via masturbation

Exclusion criteria

* Current diagnosis of a sexually transmitted infection (STI) * Previous diagnosis of hepatitis A, B, C, D, or HIV * Prior participation in this study * Participation in a clinical trial involving an intervention within the last 3 months

Design outcomes

Primary

MeasureTime frameDescription
Hyperactivation2 hoursPercentage of sperm cells displaying hyperactivated motility

Secondary

MeasureTime frameDescription
Sperm vitality2 hoursPercentage of viable sperm cells
DNA fragmentation2 hoursPercentage of TUNEL-positive sperm cells
Sperm motility2 hoursPercentage of motile sperm cells
Survival20 hoursPercentage of motile sperm cells after overnight incubation

Countries

Spain

Contacts

CONTACTMatias Gomez Elias, PhD
mgomezelias@fecundis.com+34624174355
PRINCIPAL_INVESTIGATORMariona Rius Mas, PhD

Fertty

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 2, 2026